← Back to Clinical Trials
Recruiting NCT06687356

NCT06687356 Study on the Application of Intraoperative Optical Coherence Tomography Technique in the Diagnosis and Treatment of Lens Diseases

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06687356
Status Recruiting
Phase
Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Condition Lens Diseases
Study Type INTERVENTIONAL
Enrollment 600 participants
Start Date 2024-11-27
Primary Completion 2029-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Surgery with Intraoperative Optical Coherence Tomography applicationConventional surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 600 participants in total. It began in 2024-11-27 with a primary completion date of 2029-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Accurately assessing and dealing with anterior segment changes in the eyes of patients with lens diseases can better guide the operation details during surgery and make reasonable plans for possible intraoperative and postoperative complications. Applying the intraoperative optical coherence tomography technique, this study analyzes the correlation between preoperative, intraoperative anterior segment structural changes and postoperative surgical effects in patients with lens diseases, and evaluates the clinical benefits of intraoperative optical coherence tomography technique in lens surgery. This study is intended to further improve the diagnosis and treatment quality of clinical lens diseases.

Eligibility Criteria

Inclusion Criteria: * Patients aged over 18 years old, with lens opacity or abnormal position, and other conditions meeting the surgical indications, needing lens surgery treatment, with or without anterior segment structural changes. Exclusion Criteria: * Combined with other eye diseases that seriously affect visual prognosis, serious systemic diseases and other conventional contraindications for lens surgery.

Contact & Investigator

Central Contact

Wen Xu, PHD

✉ xuwen2003@zju.edu.cn

📞 13858185223

Frequently Asked Questions

Who can join the NCT06687356 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Lens Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06687356 currently recruiting?

Yes, NCT06687356 is actively recruiting participants. Contact the research team at xuwen2003@zju.edu.cn for enrollment information.

Where is the NCT06687356 trial being conducted?

This trial is being conducted at Hangzhou, China, Hangzhou, China.

Who is sponsoring the NCT06687356 clinical trial?

NCT06687356 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology